新天地 reported revenue of ¥0.40B for the period ended 2026-06-30, +10.6% year on year. Net income was ¥0.06B, a 15.1% net margin on a 30.5% gross margin. The largest revenue line is 左旋对羟基苯甘氨酸系列产品 at 77% of the total. Free cash flow for the period was ¥0.03B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.40B | +10.6% |
| Gross profit | ¥0.12B | — |
| Operating income | ¥0.07B | — |
| Net income | ¥0.06B | -22.9% |
| Gross margin | 30.5% | Net margin 15.1% |
| Revenue Q/Q | -8.2% | — |
| Segment | Revenue | Share |
|---|---|---|
| 左旋对羟基苯甘氨酸系列产品 | ¥0.30B | 76.6% |
| 对甲苯磺酸 | ¥0.08B | 19.8% |
| 其他(补充) | ¥0.01B | 2.1% |
| 其他主营业务 | ¥0.01B | 1.5% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.28B | 69.5% |
| R&D | ¥0.02B | 4.0% |
| SG&A | ¥0.03B | 7.2% |
| Tax & other | ¥0.01B | 2.3% |
| Item | Amount |
|---|---|
| Total assets | ¥1.75B |
| Total liabilities | ¥0.22B |
| Shareholders' equity | ¥1.53B |
| Equity / assets | 87.4% |
| Operating cash flow | ¥0.04B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥0.03B |
| Cash conversion (OCF / net income) | 12% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
快可电子 ・ 金道科技 ・ 珠城科技 ・ 科源制药 ・ 金禄电子 ・ 聚胶股份 ・ 鸿日达 ・ 侨源股份 ・ 康力源 ・ 清研环境 ・ 国缆检测 ・ 东星医疗
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies